Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04762524 · ClinicalTrials.gov registry record · NA
The Impact of CRRT Modality on Filter Life
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 192
- Enrollment target
NCT04762524: Completed NA study, sponsored by University of Iowa.
NCT04762524 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 192 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04762524, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
Study Summary
The investigators plan to start patients who need CRRT on either CVVH or CVVHD by block randomization, and then to measure filter life.
Primary Outcome
Number of hours on average until filter clots
Interventions
- OTHER CVVH vs CVVHD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2020-03-21 |
| Est. Completion | 2021-03-11 |
| Phase | NA |
What the finished NCT04762524 record still lists
NCT04762524 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which CVVH vs CVVHD is the first listed.
NCT04762524 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04762524 about?
NCT04762524 is a clinical study titled "The Impact of CRRT Modality on Filter Life". The investigators plan to start patients who need CRRT on either CVVH or CVVHD by block randomization, and then to measure filter life.
What is the current status of trial NCT04762524?
This trial is currently completed. It is a NA study. The enrollment target is 192 participants. The study started on 2020-03-21. Estimated completion is 2021-03-11.
What interventions are being tested in trial NCT04762524?
The interventions under investigation include: CVVH vs CVVHD (OTHER).
Who is sponsoring clinical trial NCT04762524?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04762524's enrollment target sits among peer trials
192 570th of 2000 higher than 1,427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI